OL OLN Olin Corporation Loading... : Bullish and Bearish Analyst Opinions

Reports Olin and Huntsman merging in a stock swap, fundamental corporate event with no directional view from speaker.

SpaceX rises 7.3% in premarket, Mag 7 stocks are mixed, Domo drops 13% on strategic review, Edgewise falls 23% on trial results, Edwards Lifesciences gains 3.1% on coverage proposal, Huntsman drops 7% on merger with Olin, and Robinhood gains 2% on workforce reduction.

Cramer lists these chemical companies as the "Chem Seven," says they are "easier to own" than NVDA right now, but concludes, "I DON'T WANT THE CHEM SEVEN EITHER THOUGH." These companies are levered to a prolonged Middle East conflict and high petrochemical demand. Their appeal is entirely conditional on the war continuing. Avoid because the thesis has a short "shelf life" (could be two weeks) and is purely event-driven, making it a speculative and unreliable trade. A swift end to hostilities would immediately invalidate the investment rationale.